Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
IMTX
#2196
Immatics N.V. Ordinary Shares
10.950
0
USD
+0.74%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+0.74%
Changement Mensuel
+16.00%
Evolution sur 6 mois
+5.80%
Changement Annuel
+5.80%
Clôture Précédente
10.870
0
Open
10.950
0
Bid
Ask
Low
10.950
0
High
10.950
0
Volume
19
Marchés
Actions des Marchés US
Soins de Santé
IMTX
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Market Capitalization
1.4681 B
Employee
407
Founded
2000
CEO
Harpreet Singh
Website
www.immatics.com
Headquarter
Netherlands
FIGI
N/A
Industry
Technology
Total revenue
0
1.47 B
Market capitalization
Net income
0
Nouvelles
Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)
Le BPA de Immatics NV a dépassé les attentes de 0,13€, le CA a surpassé les prévisions
Immatics NV earnings beat by €0.13, revenue topped estimates
Nuvation Bio Inc. (NUVB) Reports Q4 Loss, Beats Revenue Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
Immatics Stock: PRAME Leader’s Transition To Commercial Reality (NASDAQ:IMTX)
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Salesforce and Micron Tech among market cap stock movers on Friday
Micron, Salesforce among market cap stock movers on Friday
L’objectif de prix de l’action Immatics relevé à 17$ contre 16$ par Leerink Partners
Immatics stock price target raised to $17 from $16 at Leerink Partners
Iovance Biotherapeutics: Several Positives, But Competition Still Threatens (NASDAQ:IOVA)